DISCOVER Groundbreaking Science – LISTEN to Prominent Experts

Do You Suffer from Neuropathy?

Optimize Blood Circulation for Significant Outcomes!


Register Now! No Purchase Required! It's Free! Limited Spaces Available!

Attend in Person or Join Webinar.

If you, or a close-relative, partner, or friend suffers from Neuropathy then please join us on Wednesday, November 8 at 18:30 (Eastern Time) for a FREE 30-minute seminar and webinar.

We will show you a new treatment, which has been clinically validated and proven to optimize blood circulation for significant outcomes!

D'OXYVA has been clinically validated for:

  • Relief from symptoms of microvascular complications

  • Significantly increased cardiac function, physical fitness, endurance and strength, muscle size, body tone, faster recovery from sports injuries and surgical trauma

  • Promoting and maintaining a healthy weight, improving general mobility, deeper, more restful sleep

  • Significant improvement of mental acuity; concentration, problem solving, multitasking, eye-hand coordination, heightened stamina, energy, and focus while managing stress

  • Improved vitals across the board during checkups with zero adverse event reports after years of regular use by people with various health, demographic, and ethnic backgrounds

WHEN: Wednesday, November 8th, 2017 6:30PM (EASTERN TIME)

EXPERT SPEAKERS: Dr. Rob Schroeder, President at Indy Health and Fitness (www.indyhealthfitness.com), Dr. Steven Hart (www.stevenhartdc.com), and Dr. Steve Pfeifer will deliver an entirely FREE 30-minute engaging and leading-edge seminar discussing the latest research and science to help you heal affordably in just a matter of a few weeks!

WHERE: Join us in person at Indy Health & Fitness (8660 Guion Rd., Indianapolis, IN 46268) to receive your FREE advanced diagnostic evaluation and your FREE single 5-minute D'OXYVA® or watch via online webinar. We will provide you details once you register. You will not be able to watch or participate without registering!

D'OXYVA® (deoxyhemoglobin vasodilator) is a novel, clinically validated and side effect-free advanced neuropathy solution. In various clinical trials, D'OXYVA has validated leading independent research results and demonstrated above-average clinical outcomes in improving a host of physiological functions at the same time.

What it does

D'OXYVA® (deoxyhemoglobin vasodilator) is the only fully non-invasive, non-irritating, non-opioid, and completely painless, transdermal (over the skin) microcirculatory solution with industry-leading clinical research results that does not break the skin's barrier.

In short, based on current leading neurology, immunology, microvascular, and cellular oxygenation science, D'OXYVA is leading the field by quickly targeting to:

Significantly lower the risk of diabetes and cardiovascular complications

Provide complete healing of difficult wounds together with major pain relief and improved quality of life:

  • Detoxify the skin and body
  • Improve sleep
  • Stamina and skin health
  • Reduce inflammation
  • And much more for all kinds of people

How it works

D'OXYVA's soft vapor solution with FDA-cleared medical CO2 readily dissolves in a molecular form in the skin to increase skin perfusion pressure, microcirculation.

It is non-electrical, handheld, painless, fast, and easy to use with no adverse side effects, according to years of user feedback and the results of past clinical trials with D'OXYVA.

It is an affordable, stand alone and adjunct application locally and all over the body. Taking D'OXYVA is easy; hold it against your skin surface for 5 minutes total, like comfortably inserting your thumb or anywhere you are hurt.

Increased oxygen-rich microcirculatory tissue perfusion is widely reported in published clinical research to improve physiological processes including but not limited to wound, tissue healing and repair, athletic performance, stamina, sleep quality, skin health, and much more.

D'OXYVA has recorded instant, outsized, and sustained improvements of the autonomic nervous system (ANS) in the brain leading to major tissue perfusion, blood circulation in macro-, and microcirculation enhancement in controlled human clinical trials (Phase I to III). These benefits result in significant improvements of essential physiological processes and clinical outcomes.

Medical CO2 gas is a widely accepted so-called gasotransmitter acting as a natural vasodilator amongst other beneficial critical signaling funtions when delivered by D'OXYVA's patented and patent-pending process.

D'OXYVA delivers the highest possible concentration of CO2 and has been clinically studied to significantly increase lasting blood flow volume in the microcirculatory system.

In addition, increased microcirculation with CO2 is widely known to increase the perfusion of oxygen.